USPTO serial 79438708
IDONTRAX
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- MORRIS, KRISTINA KLOIBER
- Law office
- TMO LAW OFFICE 116
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with IDONTRAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic products, preparations and reagents other than for medical use; screening agents for in-vitro diagnosis for scientific use; diagnostic reagents other than for medical use sold in kit form; diagnostic reagents for in-vitro use other than for medical use; reagents for in vitro laboratory uses other than for medical use; chemical preparations intended for use in DNA analysis, other than for medical use; enzymes, other than for medical use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents; reagents for nucleic acid amplification other than for medical use. | ACTIVE | — |
| 005 | Pharmaceutical products; products, preparations and reagents for diagnosis for medical or veterinary use; diagnostic materials; reagents for medical use; chemical reagents for medical or veterinary use; organic reagents for medical or veterinary use; reagents for analysis for medical use; reagents for diagnostic tests for medical use; reagents for genetic testing in medicine; reagents for in vitro use in laboratories for medical use; in vitro diagnostic preparation for medical use; indicators for medical diagnosis; diagnostic substances for medical use; diagnostic biomarking reagents for medical use; diagnostic test kits for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects; chemical preparations intended for use in DNA analysis for medical use; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use; diagnostic material for medical and veterinary use. | ACTIVE | — |
| 010 | Apparatus, tools and instruments for medical diagnosis; DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction [PCR] instrument for medical use; samplers for medical use. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 24, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 24, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 15, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 12, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 11, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |